Zusammenfassung
In diesem Übersichtsartikel sind die naturwissenschaftlichen und klinischen Ergebnisse über Anthralin zusammengefaßt worden, um einen Überblick über dieses altbewährte antipsoriatische Lokaltherapeuticum zu gewähren. Neben der Chemie und Biochemie wird auf Untersuchungen zur Galenik, zur Pharmakokinetik und zum Metabolismus dieses Medikaments eingegangen. Ausführlich werden auch die Wirkungsweise des Anthralins auf cellulärer und molekularer Ebene erläutert und neue Behandlungsweisen beschrieben, die auf neuen Erkenntnissen bezüglich der Penetrationskinetiken beruhen.
Summary
In this review, data from fundamental and clinical literature on anthralin have been brought together to provide an overview of this well studied antipsoriatic drug. In addition to chemistry and biochemistry, attention is focused on formulation studies, pharmacokinetics and metabolism of the drug. Details of the action of anthralin at the cellular and molecular levels are highlighted, and novel treatment modalities are described which are based on some new basic considerations of the penetration kinetics in normal and diseased skin.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Auerbach, M E.: J. Amer, pharm. Ass. 34, 310–311 (1954).
Auterhoff, H, Kinsky, G.: Arch. Pharm. 299, 783–788 (1966).
Baxter, D L, Stoughton, R B.: J. invest. Derm. 54, 410 (1970).
Beyrich, Th.: Pharmazie 17, 280–282 (1962).
Biersack, H J, Rodermund, D E, Winkler, C.: Z. Hautkr. 54, 637–640 (1979).
Biles, J A.: J. Amer, pharm. Ass. 44, 74–76 (1955).
Bock, F G, Bums, R.: J. nat. Cancer Inst. 30, 393–397 (1963).
Bohlen, P, Grove, J, Beya, M F, Koch-Weser, J, Henry, M H, Grosshans, E.: Europ. J. clin. Invest. 8, 215–218 (1978).
Born, W.: Hautarzt 20, 178–181 (1969).
Bouas-Laurent, H, Lapouyade, R.: C. R. Acad. Sci. (Paris) t. 264, 1061–1064 (1967).
Brody, I, Johannson, A.: Cutan. Path. 4, 233–243 (1977).
Brown, C.: Private Communication.
Caron, J C, Shroot, B.: J. pharm. Sci. (in press).
Cavey, D, Caron, J C, Shroot, B.: Brit. J. Pharmacol. (Suppl.) in press (1981).
Champion, R H.: Brit. Med. J. 1966, I, 993–995.
Chapman, O L, Lee, K.: J. org. Chem. 34, 4166–4168 (1969).
Clark, J M, Hanawalt, P C.: Brit. J. Derm. (Suppl.) in press (1981).
Cohen, S R, Carter, D M, Nagy, L E, Shih, M C, Wayne, S J.: J. invest. Derm. 76, 305 (1981).
Comaish, S, Smith, J, Seville, R H.: Brit. J. Derm. 84, 282 (1971).
Cotton, D W K, Rossum, E van.: Arch. derm. Forsch. 252, 147–149 (1975).
Coulson, C A, Orgel, L E, Taylor, W, Weiss, J.: J. Amer. chem. Soc. 77, 2961–2962 (1955).
Cox, A J, Watson, W: In: Färber, E M, Cox, A J. (eds.) Psoriasis — Proc. Internat. Symp., pp. 151–159, Stanford University Press. Stanford 1971.
Cripps, D J, Lowe, N J.: Clin. exp. Derm. 4, 477–483 (1979).
Crombag, N, Bauer, F.: Brit. J. Derm. 100, 602–603 (1979).
Diezel, W, Meffert, H, Sonnichsen, N.: Dermatologica 150, 154–162 (1975).
Doering-Petersen, H.: Untersuchungen zur Pharmakologie und Toxikologie des Antiacanthoticums Anthralin (Bayer), Med. Diss. Düsseldorf (1958).
van Duuren, B L, Segal, A, Tseng, Rusch, G M, Loewengart, G, Mate, U, Roth, D, Smith, A, Melchionne, S.: J. med. Chem. 21, 26–31 (1978).
Eichholz, E.: Derm. Wschr. 88, 161–170 (1929).
Elsabbagh, H M, Whitworth, C W, Schramm, L C.: J. pharm. Sci. 68, 388–390 (1979).
Farber, E M, Harris, D R.: Arch. Derm. 101, 189–381 (1970).
Fisher, L B.: Clin. Res. 20, 212 (1972).
Fisher, L B, Maibach, H I.: In: Färber, E M, Cox, A J. (eds.) Psoriasis — Proc. Internatl. Symp., pp. 335–345, Stanford University Press, Stanford 1971.
Fisher, L B, Maibach, H I.: Arch. Derm. 108, 374–377 (1973).
Fisher, L B, Maibach, H I.: J. invest. Derm. 54, 338–341 (1975).
Fischer, T, Juhlin, L.: Arch. Derm. 113, 852 (1977).
Fox, H W, Bock, F G.: J. nat. Cancer Inst. 38, 789–795 (1967).
Franz, E.: Arch. derm. Forsch. 258, 103 (1977).
Franz, E, Ippen, H.: Arch. derm. Forsch. 255, 102 (1976).
Frosch, P, Duncan, S, Kligman, A M.: Brit. J. Derm. 102, 263–274 (1980).
Frosch, P, Wendt, H, Kligman, A M.: Arch. derm. Res. 261, 108 (1978).
Frosch, P, Wendt, H.: Arch. derm. Res. 270, 252 (1981).
Fry, L, McMinn, R M H.: Brit. J. Derm. 80, 113–115 (1968).
Galewsky: Derm. Wschr. 62, 113–115 (1916).
Gay, M W, Moore, W J, Morgan, J M, Montes, L F.: Arch. Derm. 105, 213-215.
Gelfant, C.: Brit. J. Derm. 95, 577–590 (1976).
Gerny, H, Storck, H.: Praxis 65, 641–645 (1976).
Grosshans, E, Bohlen, P, Henry, M, Grove, J, Beya, M F, Koch-Weser, J.: J. invest. Derm. 70, 227 (1978).
Hammar, H.: J. invest. Derm. 54, 121–125 (1970).
Hammar, H.: J. invest. Derm. 65, 315–319 (1975).
Hammar, H.: Arch. derm. Forsch. 252, 217–236 (1975).
Harris, D R, Ferrington, R A.: Färber, E M, Cox, A J. (eds.) Psoriasis — Proc. Internatl. Symp., pp. 357–365 Stanford University Pess. Stanford 1971.
Heite, H.-J, Kleinhans, D.: Arch. klin. exp. Derm. 212, 431–437 (1961).
Hindson, C.: Clin. Trials J. 17, 131–136 (1980).
Hooper, G, Ayres, P J.: Clin. exp. Derm. 4, 315–323 (1979).
Ingram, J T.: Brit. Med. J. 1953, II, 591–594.
Ionescu-Solomon, I, Constantinescu, T, St. Gamenti, U.: Rev. Chim. 17, 490–493 (1966).
Ippen, H.: Planta med. 7, 423–426 (1959).
Ippen, H.: Dermatologica 119, 211–220 (1959).
Ippen, H.: Arch. klin. exp. Derm. 227, 202–216 (1966).
Ippen, H.: Arzneimittel-Forsch. 24, 814–815 (1974).
Ippen, H, Montag, T.: Arzneimittel-Forsch. 8, 778–779 (1958).
Jacques, Y, Reichert, U.: Brit. J. Derm. (Suppl.) in press (1981).
Juhlin, L.: Brit. J. Derm. (Suppl.) in press (1981).
Kammerau, B, Zesch, A, Schaefer, H.: J. invest. Derm. 64, 145–149 (1975).
Kido, H, Fernelius, W C, Haas, C G.: Anal. chim. Acta 23, 116–123 (1960).
Klem, E B.: J. invest. Derm. 70, 27–32 (1978).
Korting, G W.: Therapie der Hautkrankheiten, 2. Aufl., p. 14., Schattauer Stuttgart-New York 1970.
Krebs, A.: Habilitationsscrift Universität Bern (1965).
Krebs, A, Schaltegger, H.: Dermatologica 131, 1–27 (1965).
Krebs, A, Schaltegger, H.: Experientia XXI/3, 128–129 (1965).
Krebs, A, Schaltegger, H.: Hautarzt 20, 204–209 (1969).
Kulkarni, M S, Yielding, K L.: Biochem. biophy. Res. Commun. 83, 1531–1537 (1978).
Kunze, J, Munk, A, Muller, R.: Arch. derm. Res. 270, 224 (1980).
Liden, S, Michaelsson, G.: Brit. J. Derm. 91, 447–456 (1974).
Mackey, J P.: Clin. Trials J. 17, 137–143 (1980).
Marriott, P J, Munro, D D.: Brit. J. Derm. 94 (Suppl. 12), 101–104 (1976).
Martinmaa, J, Mustakallio, K K, Vanhala, L.: J. invest. Derm. 70, 229 (1978).
Meffert, H, Reich, P.: Derm. Mschr. 155, 157–161 (1969).
Meiers, H G, Kuhling, K, Ippen, H.: Dermatologica 136, 497–503 (1968).
Misch, K, Davies, M, Greaves, M, Couts, A.: Brit. J. Derm. (Suppl.) in press (1981).
Montes, L F, Wilborn, W H, Brody, I.: J. cutan. Path. 6, 445–456 (1979).
Morison, W L, Parrish, J A, Fitzpatrick, T B.: Brit. J. Derm. 98, 125–132 (1978).
Moss, C, Friedmann, P, Shuster, S.: Lancet 1980, II, 922.
Mustakallio, K K.: Acta derm, vener. 59, 125–132 (1979).
Mustakallio, K K: Acta derm, vener. 60, 169–171 (1979).
Mustakallio, K K.: Brit. J. Derm. (Suppl.) in press (1981).
Mustakallio, K K, Brandt, H.: Brit._J. Derm. (Suppl.) in press (1981).
Orfanos, C E, Steigleder, G K.: Z. Hautkr. 51, 473–480 (1976).
Parikh, P M, Vadoria, D J, Mukherji, S P.: J. Pharm. Pharmacol. 11, 314–317 (1959).
Patzscke, W.: Arch. Derm. Syph. (Berlin) 141, 123–151 (1922).
Proctor, M S, Fletcher, H V, Shukla, J B, Rennert, O M.: J invest. Derm. 65, 409–411 (1975).
Proctor, S, Orenberg, E K, Farber, E M.: J. invest. Derm. 71, 279 (1978).
Pullmann, H, Zingsheim, M, Steigleder, G K, Orfanos, C F.: Z. Hautkr. 51, 861–871 (1976).
Raab, W.: Ann. ital. Derm. clin. sper. 22, 322–339 (1968).
Raab, W.: Arch. klin. exp. Derm. 234, 44–51 (1969).
Raab, W.: Hautarzt 26, 452–455 (1975).
Raab, W.: Hautarzt 26, 456–459 (1975).
Raab, W.: Brit. J. Derm. 95, 193–196 (1976).
Raab, W, Gmeiner, B M.: Arch. derm. Forsch. 251, 87–94 (1974).
Raab, W, Gmeiner, B M.: Dermatologica 150, 267–276 (1975).
Raab, W, Patermann, F.: Naturwissenschaften 53, 614–615 (1966).
Raab, W, Patermann, F.: Arch. klin. exp. Derm. 226, 144–152 (1966).
Raab, W, Siber, H.: Arch. derm. Forsch. 249, 179–189 (1974).
Rassner, G.: Arch. derm. Forsch. 241, 237–244 (1971).
Rassner, G.: Arch. derm. Forsch. 243, 47–51 (1972).
Retzow, A, Schaublin, J, Wiegrebe, W.: Pharm. Ztg. 123, 1808–1810 (1978).
Rogers, S, Marks, J, Shuster, S, Briffa, D V, Warin, A, Greaves, M W.: Lancet 1979, I, 455–458.
Runne, U.: Hautarzt 25, 199–200 (1974).
Runne, U, Schopf U, Schöpf R, Kelm, F.: Arch. derm. Res. 270, 223–224 (1981).
Russell, D H, Stawiski, M A, Duell, E A, Vorhees, J J.: Pharmacologist 18, 157 (1976).
Saihan, E, Albano, J, Burton, J L.: Brit. J. Derm. 101, 102–103 (1979).
Salim, E F, Manni, P E, Sinsheimer, J E.: J. pharm. Sci. 53, 391–394 (1964).
Schaefer, H.: Arch. klin. exp. Derm. 237, 240–245 (1970).
Schaefer, H, Färber, E M, Goldberg, L, Schalk, W.: Brit. J. Derm. 101, 571–573 (1980).
Schalla, W, Bauer, E, Wesendahl, C, Goldberg, L, Färber, E M, Schaefer, H.: Arch. derm. Res. 267, 203 (1980).
Schalla, W, Bauer, E, Schaefer, H.: Acta derm. 6, 3–11 (1980).
Schalla, W, Bauer, E, Schaefer, H.: Brit. J. Derm. (Suppl.) in press (1981).
Schalla, W et al.: unpublished results.
Schalla, W.: unpublished observations.
Schmid, E H, Meisel, C.: Therapiewoche 19, 1655–1662 (1973).
Schmoeckel, Ch.: Hautarzt 31, 556 (1980).
Schultz, O E, Schultze-Mosgau, H H.: Arch. Pharm. 298, 273–281 (1965).
Segal, A, Katz, Ch, van Duuren, B L.: J. med. Chem. 14, 1152–1154 (1971).
Selim, M, Goldberg, L H, Schaefer, H, Bishop, S C, Färber, E M.: Brit. J. Derm. (Suppl.) in press (1981).
Seville, R H.: Brit. J. Derm. 93, 205–208 (1975).
Seville, R H.: Brit. J. Derm. 95, 643–646 (1976).
Skerrow, D, Hunter, I.: Biochim. biophys. Acta 537, 474–484 (1978).
Squire, B.: Brit. Med. J. 1877, I, 546.
Squire, B.: Brit. Med. J. 1877, I, 199.
Steigleder, G K, Schumann, H, Lennartz, K J.: Arch. derm. Forsch. 246, 231–235 (1973).
Stuttgen, G, Flesch, U, Siebel, T.: Brit. J. Derm. (Suppl.) in press (1981).
Suurmond, D.: Dermatologica 131, 357–366 (1965).
Swanbeck, G.: Biochim. biophys. Acta 123, 630–633 (1966).
Swanbeck, G.: Acta derm, vener. 51, 107–111 (1971).
Swanbeck, G, Zetterberg, G.: Acta derm, vener. 51, 41–44 (1971).
Thielemann, H.: Sci. Pharm. 42, 55–57 (1971).
Tsukida, K.: J. pharm. Soc. Jap. 74, 1069–1092 (1954).
Unna, P G.: Derm. Wschr. 8, 116–137, 150-163, 175-183 (1916).
Unna, P G.: Derm. Wschr. 8, 811–819 (1919).
Walter, J F, DeQuoy, P R.: Arch. Derm. 114, 1463–1465 (1978).
Walter, J F, Stoughton, R B, DeQuoy, P R.: Clin. Res. 26, 211A (1978).
Whitefield, M.: Arzneimittel-Forsch. 20, 137–139 (1970).
Wiegrebe, W.: Arzneimittel-Forsch. 29, 8 (1979).
Wiegrebe, W, Retzow, A, Plumier, E.: Brit. J. Derm. (Suppl.) in press (1981).
Willis, I, Harris, D R.: Arch. Derm. 107, 358–362 (1973).
Wilson, P D, Ive, F A.: Brit. J. Derm. 103, 105–106 (1980).
Young, E.: Brit. J. Derm. 82, 516–520 (1970).
Young, L M, de, Sun, V.: Vlin. Res. 27, 524A (1979).
Zetterberg, G.: Brit. J. Derm. (Suppl.) in press (1981).
Zetterberg, G, Swanbeck, G.: Acta derm.-vener. 51, 45–49 (1971).
Zwaving, J H.: Pharmacol. 20, 65–75 (1980).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Schaefer, H., Schalla, W., Shroot, B. (1984). Anthralin — Facts, Trends and unresolved Problems. In: Hornstein, O.P., Schnyder, U.W., Schönfeld, J. (eds) Neue Entwicklungen in der Dermatologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69831-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-69831-6_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-13553-1
Online ISBN: 978-3-642-69831-6
eBook Packages: Springer Book Archive